Innovative wearable Bloomer Tech offers a clinician-grade wearable garment that monitors cardiovascular signals in women, presenting a direct sales opportunity to medical device distributors, hospitals, and clinics focusing on women's health and cardiology.

Clinical validation With NIH funding and multiple clinical study initiatives, there's a strong narrative for partnerships in research institutions and trial sites seeking validated digital biomarkers and end-to-end data collection capabilities.

Strategic partnerships The company has previously attracted investments from MIT-affiliated networks and impact-focused funds, signaling openness to collaboration with accelerators, health tech investors, and corporate venturing units.

Women’s health focus Target buyers include women’s health clinics, cardiology practices, and employer health programs looking to improve women's cardiovascular outcomes with novel digital biomarkers and noninvasive monitoring.

Early-stage traction Revenue is in the low millions with a small team, indicating a high value proposition with scalable, partner-led go-to-market strategies such as channel partnerships, research collaborations, and pilot programs.